Literature DB >> 24452398

Rational hopping of a peptidic scaffold into non-peptidic scaffolds: structurally novel potent proteasome inhibitors derived from a natural product, belactosin A.

Shuhei Kawamura1, Yuka Unno, Takatsugu Hirokawa, Akira Asai, Mitsuhiro Arisawa, Satoshi Shuto.   

Abstract

Rational scaffold hopping of a natural product belactosin A derivative was successfully achieved based on the pharmacophore model constructed. The peptidic scaffold was replaced by significantly simplified non-peptidic scaffolds, by which weak belactosin A (IC50 = 1440 nM) was converted into highly potent non-peptidic inhibitors (IC50 = 26-393 nM).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452398     DOI: 10.1039/c3cc48818g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

1.  A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.

Authors:  Mingzhao Zhu; Wayne D Harshbarger; Omar Robles; Joanna Krysiak; Kenneth G Hull; Sung Wook Cho; Robyn D Richardson; Yanyan Yang; Andres Garcia; Lindsey Spiegelman; Bianca Ramirez; Christopher T Wilson; Ju Anne Yau; James T Moore; Caitlen B Walker; James C Sacchettini; Wenshe R Liu; Stephan A Sieber; Jeffrey W Smith; Daniel Romo
Journal:  Bioorg Med Chem       Date:  2017-01-19       Impact factor: 3.641

2.  Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents.

Authors:  Garima Priyadarshani; Anmada Nayak; Suyog M Amrutkar; Sarita Das; Sankar K Guchhait; Chanakya N Kundu; Uttam C Banerjee
Journal:  ACS Med Chem Lett       Date:  2016-09-20       Impact factor: 4.345

3.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

4.  Design of a Structurally Novel Multipotent Drug Candidate by the Scaffold Architecture Technique for ACE-II, NSP15, and Mpro Protein Inhibition: Identification and Isolation of a Natural Product to Prevent the Severity of Future Variants of Covid 19 and a Colorectal Anticancer Drug.

Authors:  Sourav Pakrashy; Prakash K Mandal; Surya Kanta Dey; Sujata Maiti Choudhury; Fatmah Ali Alasmary; Amani Salem Almalki; Md Ataul Islam; Malay Dolai
Journal:  ACS Omega       Date:  2022-09-10

5.  A chemical family-based strategy for uncovering hidden bioactive molecules and multicomponent interactions in herbal medicines.

Authors:  Hui-Peng Song; Si-Qi Wu; Haiping Hao; Jun Chen; Jun Lu; Xiaojun Xu; Ping Li; Hua Yang
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.